Premier Health of America Inc (PHA) AI Stock Analysis

• Market Cap: C$1.11M
• Dividend Yield: N/A
• Average Volume (3M): 33.75K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.18
• Revenue Growth: -22.61%
• EPS Growth: 7.72%
• Country: CA
• Employees: 589
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): -0.05
• Shares Outstanding: 55,514,153
• 10 Day Avg. Volume: 13,466
• 30 Day Avg. Volume: 33,746
• PEG Ratio: >-0.01
• Price to Book (P/B): -0.15
• Price to Sales (P/S): 0.02
• P/FCF Ratio: 0.14
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 0.01
• Revenue Forecast (FY): C$157.17M

• Rating: 46 Neutral
• Price Target: C$0.02 ▲(0.00% Upside)
• Action: Reiterated Date: 02/27/26
• Date: Action: Reiterated 02/27/26

The score is primarily held down by weak financial performance—ongoing losses, declining revenue, and a stressed balance sheet with negative equity—despite improved recent cash flow. Technicals are mixed but skew weak relative to longer-term averages, and valuation support is limited due to negative earnings and no dividend data.

Positive Factors

Improving cash generation

TTM operating and free cash flow turned positive and improved year-over-year, reflecting better cash discipline. This durable cash generation expands runway to fund operations and service obligations, lowering immediate dependence on dilutive financing while profitability is addressed.

Historical margin potential

The company’s track record of higher margins indicates operational levers (pricing, mix, productivity) that can be redeployed. If revenue stabilizes, this structural ability supports margin recovery through cost control and scale, offering a credible path to improved profitability over months.

Substantial asset base and operations

A sizable asset base and operational footprint underpin service delivery and provide options for monetization or restructuring. Assets and scale support continuity of care, potential operational efficiencies, and can be used to shore up liquidity or negotiate with creditors over the medium term.

Negative Factors

Negative equity and high leverage

Negative shareholders’ equity and elevated debt show a weakened capital structure that limits financial flexibility. This increases refinancing and dilution risk, constrains strategic options, and could force asset sales or costly capital raises to meet obligations over the coming months.

Declining revenue and operating losses

Ongoing operating and net losses alongside declining revenue indicate deteriorating core economics. Reduced demand or pricing pressure worsens fixed-cost absorption and makes sustained margin recovery harder, increasing the likelihood of prolonged restructuring or capital needs.

Volatile cash flow vs debt load

Although recent cash flow improved, historical volatility and cash generation that remains modest versus the debt burden raise refinancing risk. Inconsistent cash makes funding capital needs or growth uncertain and increases reliance on external capital under stress.

Premier Health of America Inc Business Overview & Revenue Model

Company Description

Premier Health of America Inc., a specialized healthcare services company, provides staffing and outsourced service solutions for healthcare needs in Canada. It also offers health consulting, nursing, and health-care services in remote communities, as well as medical transport services; and Code Bleu, an agency to employ nurses, caregivers, dental staff, and other health-related personnel. The company provides its services through PSweb, a CRM platform. It serves governments, corporations, individuals, public and private hospitals, medical clinics, and retirement homes. The company was founded in 2003 and is headquartered in Blainville, Canada.

How the Company Makes Money

PHA generates revenue through multiple streams, primarily from the sales of medical supplies and equipment to healthcare providers and patients. The company also earns income from its home healthcare services, which include nursing, rehabilitation, and telehealth consultations. Additionally, PHA has established partnerships with healthcare facilities and insurance companies that facilitate service contracts and reimbursement agreements, contributing significantly to its earnings. The increasing demand for home healthcare solutions and the expansion of telehealth services in response to changing healthcare dynamics further bolster PHA's revenue model.

Premier Health of America Inc Financial Statement Overview

Summary

Overall fundamentals are weak: TTM profitability deteriorated into meaningfully negative margins with operating and net losses, and revenue declined. The balance sheet is stressed with negative equity and high leverage, raising refinancing/dilution risk. A partial offset is improving TTM operating cash flow and free cash flow, though still modest versus debt and historically volatile.

Income Statement

TTM (Trailing-Twelve-Months) results show continued operating losses with negative operating earnings and a sizable net loss, and profitability has deteriorated versus earlier years (margins moved from positive in 2021–2023 to meaningfully negative in 2024–TTM). Revenue has also declined in TTM after previously strong growth, which adds pressure to fixed-cost absorption. The main positive is that the business has demonstrated the ability to produce higher margins historically, but the recent trajectory is clearly unfavorable.

Balance Sheet

Leverage and capitalization are the key concerns. Stockholders’ equity is negative in TTM, which implies a weakened capital base and limits financial flexibility. Total debt remains high relative to the company’s size, and the shift from positive equity in 2024 to negative equity in TTM suggests balance-sheet strain. While total assets remain substantial, the combination of losses and negative equity elevates refinancing and dilution risk.

Cash Flow

Cash generation is a relative bright spot: TTM (Trailing-Twelve-Months) operating cash flow and free cash flow are positive and have grown year-over-year, indicating improved cash discipline despite accounting losses. However, cash flow still appears modest relative to the debt load, and past periods included negative operating and free cash flow (notably 2023), highlighting volatility and execution risk.

Breakdown	TTM	Dec 2024	Sep 2024	Sep 2023	Sep 2022	Sep 2021
Income Statement
Total Revenue	87.67M	101.97M	158.19M	90.39M	80.51M	66.63M
Gross Profit	4.73M	8.40M	27.89M	23.34M	20.08M	16.25M
EBITDA	-4.32M	-3.67M	384.00K	5.87M	5.61M	5.90M
Net Income	-15.73M	-15.44M	-12.49M	-1.70M	-111.51K	1.50M
Balance Sheet
Total Assets	42.63M	47.22M	73.72M	56.71M	57.09M	39.13M
Cash, Cash Equivalents and Short-Term Investments	92.00K	1.40M	1.50M	1.15M	5.12M	2.68M
Total Debt	45.34M	45.34M	49.85M	27.27M	22.84M	12.30M
Total Liabilities	56.43M	58.49M	69.64M	40.27M	38.62M	21.81M
Stockholders Equity	-13.80M	-11.27M	4.08M	16.44M	18.47M	17.32M
Cash Flow
Free Cash Flow	13.71M	12.33M	3.02M	-3.20M	3.38M	24.13K
Operating Cash Flow	14.78M	12.45M	5.93M	-1.27M	4.04M	1.97M
Investing Cash Flow	-1.91M	-2.53M	-26.43M	-3.33M	-12.67M	-16.08M
Financing Cash Flow	-12.82M	-10.02M	20.85M	625.00K	11.07M	15.56M

Premier Health of America Inc Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.02
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:PHA, the sentiment is Negative. The current price of 0.02 is above the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.03, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 47.97 is Neutral, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:PHA.

Premier Health of America Inc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
DR	76 Outperform	C$301.32M	2.37	39.85%	2.35%	-40.05%	558.77%
CRRX	59 Neutral	C$242.16M	3,810.00	0.11%	1.03%	0.19%	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
PHA	46 Neutral	C$1.11M	-0.07	-1473.72%	―	-22.61%	7.72%
NUMI	41 Neutral	C$13.86M	―	―	―	―	―

Premier Health of America Inc Corporate Events

Premier Health Narrows Focus to Travel Nurses as Revenue Slides in Q1 2026

Premier Health of America reported first-quarter 2026 revenues of $17.8 million, down sharply from $32.1 million a year earlier, with gross margin slipping to 15.28% and adjusted EBITDA essentially flat at $5,000. The company posted a net loss of $2.5 million, slightly worse than last year, as weaker volumes in British Columbia and the formal discontinuation of unprofitable Per Diem and transportation operations weighed on results.

Management is concentrating resources on its travel nurse and northern communities services, which are generally performing well outside British Columbia. The strategic pivot centers on nationwide Travel Nurse operations alongside ongoing cost-cutting, debt management, and efficiency efforts, positioning Premier Health to compete more effectively as health authorities centralize service procurement and favor scale players like its SSI unit.

The most recent analyst rating on (TSE:PHA) stock is a Hold with a C$0.01 price target. To see the full list of analyst forecasts on Premier Health of America Inc stock, see the TSE:PHA Stock Forecast page.

Premier Health of America Widens Loss as It Exits Per Diem Segment and Refocuses on Travel Nurses

Premier Health of America reported a sharp year-over-year decline in fiscal 2025 results, with annual revenues falling to $101.97 million from $158.19 million and adjusted EBITDA dropping to $1.67 million from $6.56 million, alongside a widened net loss of $15.44 million. Fourth-quarter performance reflected these pressures, as revenue slid to $20.79 million and net loss deepened to $6.5 million, driven primarily by reduced volumes in Quebec and British Columbia and the continued impact of Quebec’s Bill 10, which capped rates for independent labor and effectively reduced the contribution of the Per Diem segment to under 4% of annual revenue before its abandonment in early 2026. In response, the company is executing a cost-reduction and reorganization plan, notably cutting staff in Quebec and at the corporate level, trimming salary expenses by $0.7 million in the quarter despite one-time management benefits, and adjusting its British Columbia cost structure, while strategically pivoting its focus toward travel nurse services and evaluating expansion opportunities in home care and Ontario tenders to restore growth and improve operational efficiency.